Heterozygous large deletion mimicking homozygous substitution in MCFD2 in a patient with combined Factor V and Factor VIII deficiency

Documenti analoghi

• Utilising Thrombin Generation Assay to Guide Co‐Administration of Factor Therapies With Fitusiran
  di: Yesim Dargaud, et al.
  Pubblicazione: (2025)
• In vitro combined haemostatic efficacy of emicizumab and extended half‐life factor VIII compounds
  di: Laurie Josset, et al.
  Pubblicazione: (2025)
• Genetic Analysis of a Family With Hereditary Factor V Deficiency Induced by Compound Heterozygous Variants (IVS24+3A>T and p.Asp2222Gly)
  di: Ben Huang, et al.
  Pubblicazione: (2026)
• Factor X and Combined Factor VIIa/Factor X Augment Coagulation Potential in a Plasma Model of Tissue Factor Pathway Inhibitor‐Reduced Haemophilia State
  di: Shigeharu Oh, et al.
  Pubblicazione: (2026)
• Factor VII Padua in Iran: A Study on 150 Patients With Factor VII Deficiency
  di: Seyed Mehrab Safdari, et al.
  Pubblicazione: (2025)